T-cell dysfunction as a potential contributing factor in post-COVID-19 mucormycosis

Himanshu Dandu1, Manish Kumar2, Hardeep Singh Malhotra3

  • 1Department of Internal Medicine, King George's Medical University, Lucknow, India.

Mycoses
|October 28, 2022
PubMed
Abstract

Insights

T-cell exhaustion is more severe in non-COVID mucormycosis than in post-COVID cases, leading to poorer outcomes. This study highlights differences in T-cell immune dysfunction between these patient groups.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Oncology

Background:

  • The second wave of COVID-19 in India saw a rise in mucormycosis cases, often linked to immunosuppressive drugs and underlying conditions.
  • While mucormycosis cases increased post-COVID-19, their mortality rates were lower than in non-COVID mucormycosis cases.

Purpose of the Study:

  • To investigate detailed T-cell characteristics in post-COVID and non-COVID mucormycosis patients.
  • To identify underlying differences in T-cell immune dysfunction between these groups.

Main Methods:

  • Histopathologically confirmed mucormycosis cases (13 post-COVID, 13 non-COVID) and 15 healthy individuals were studied.
  • Flow cytometry was used to evaluate T-cell activation markers (CD44, HLADR, CD69, CD38) and exhaustion markers (CTLA, PD-1, LAG-3, TIM-3).

Main Results:

  • All mucormycosis patients exhibited significant T-cell depletion compared to healthy individuals.
  • Both post-COVID and non-COVID groups showed increased T-cell activation and exhaustion.
  • Non-COVID mucormycosis patients displayed significantly higher CD4+ T-cell activation (HLADR, CD38) and marked T-cell exhaustion (LAG-3 expression on CD4+ and CD8+ T cells) compared to post-COVID patients.

Conclusions:

  • Non-COVID mucormycosis cases exhibit more pronounced T-cell exhaustion than post-COVID cases.
  • T-cell immune dysfunction appears more severe in non-COVID mucormycosis, characterized by continuous activation followed by extreme exhaustion.
  • These findings suggest a link between the severity of T-cell immune dysfunction and patient outcomes in mucormycosis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
336
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
69.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
447
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
22